Epidemiology of head and neck cancers: an update

Curr Opin Oncol. 2020 May;32(3):178-186. doi: 10.1097/CCO.0000000000000629.

Abstract

Purpose of review: This review attempts to give an update of epidemiological knowledge on head and neck cancers (HNC).

Recent findings: Worldwide, from 1990 to 2017, incidence rates for larynx and nasopharyngeal cancers decreased, whereas they increased for oro/hypopharyngeal cancers and lip/oral cavity cancers. They are still markedly higher among men than women. South Asia has the highest HNC incidence rate, followed by Europe, North America, and Australasia.Tobacco and alcohol remain the major risk factors. Rate of cancers attributable to human papillomavirus (HPV) among HNCs is highly depending on world region and tobacco use prevalence. It increases in high-income countries. In the US population, the number of HPV-attributable oropharyngeal cancers now exceeds the number of cervix cancers. HPV vaccination for boys is recommended in an increasing number of countries. Many occupations are associated with an increased HNC risk. Fruits and vegetables intake have a protective effect against HNC.

Summary: To decrease HNC incidence, measures to reduce tobacco use and alcohol consumption remain essential. Improvement of HPV vaccination coverage is also a major objective. Reduction of carcinogens at occupation, protection of workers from carcinogen exposures, education for better diet, and easy and affordable access to fruits and vegetables can contribute to incidence decrease.

Publication types

  • Review

MeSH terms

  • Global Health
  • Head and Neck Neoplasms / epidemiology*
  • Head and Neck Neoplasms / etiology
  • Head and Neck Neoplasms / prevention & control
  • Humans
  • Incidence
  • Papillomavirus Infections / prevention & control
  • Papillomavirus Vaccines / administration & dosage
  • Risk Factors
  • Socioeconomic Factors

Substances

  • Papillomavirus Vaccines